ARS Pharmaceuticals, Inc. (SPRY) Misses Q1 EPS by 12c, Beats on Revenue
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- S&P 500, Nasdaq advance as oil eases ahead of Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
| (NASDAQ: SPRY) | Delayed: 3.76 -0.16 (4.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.92 | 52 Week High | $ | |||
| Open | $3.92 | 52 Week Low | $ | |||
| Day High | $3.95 | P/E | N/A | |||
| Day Low | $3.74 | EPS | $ | |||
| Volume | 270,723 | |||||
